| Literature DB >> 34017199 |
Yang Luo1, Min-Hao Yu1, Yi-Zhou Huang1, Ran Jing1, Jun Qin1, Shao-Lan Qin1, Jay N Shah1,2, Ming Zhong1.
Abstract
BACKGROUND: Preservation of the left colic artery in low-tie (LT) of inferior mesenteric artery remains controversial compared to high-tie (HT) in the colon and rectal cancers, for lymph node dissection, anastomotic leakage, and oncological outcome. This cohort study aims to analyze short- and long-term outcomes of laparoscopic anterior resections in LT vs HT for rectal cancers.Entities:
Keywords: Clavien-Dindo complications; anastomotic leakage; laparoscopic anterior resection; left colic artery; low-tie high-tie of the inferior mesenteric artery; rectal cancer
Year: 2021 PMID: 34017199 PMCID: PMC8131009 DOI: 10.2147/CMAR.S282986
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1(A) High-tie, the IMA is ligated at its origin within 1 cm from the aorta, with dissection of the apical lymph nodes (LN); (B) Low-tie, the IMA and the proximal left colic artery (LCA) are skeletonized, LCA is preserved, the superior rectal artery (SRA) is ligated, LN dissection medially along the IMA root, including the abdominal aortic (AA) plane.
Figure 2(A) Tension-free anastomosis after low-tie of IMA and preservation of LCA; (B) Completion of laparoscopic surgery for rectal cancer and skin closure of ports; (C-D) Retrieved specimen after low-tie and total mesorectal excision (TME) for rectal cancer.
Clinicodemographic Profile of Patients with Low-Tie vs High-Tie of the Inferior Mesenteric Artery in Laparoscopic Anterior Resection of Rectal Cancer, N=614
| Clinical Profile | LTa 236 (38.44%) | HTb 378 (61.56%) | p-value |
|---|---|---|---|
| Age (years) | 62.05 ± 0.68 | 63.25 ± 0.58 | 0.189 |
| BMI | 22.12 ± 0.18 | 22.34 ± 0.15 | 0.372 |
| Gender | |||
| Male | 140 (59.32) | 220 (58.20) | 0.784 |
| Female | 96 (40.68) | 158 (41.80) | |
| Diabetes and/or hypertension | |||
| Yes | 45 (19.07) | 48 (12.69) | 0.032 |
| No | 191 (80.93) | 330 (87.31) | |
| Neoadjuvant | |||
| Yes | 34 (14,41) | 43 (11.38) | 0.270 |
| No | 202 (85.59) | 335 (88.62) | |
| ASA grade | |||
| 1 | 126 (53.40) | 189 (50.00) | 0.547 |
| 2 | 58 (24.58) | 108 (28.57) | |
| 3 | 52 (22.02) | 81 (21.43) | |
| Tumor size (cm) | |||
| ≤ 5 | 152 (64.41) | 223 (58.99) | 0.181 |
| > 5 | 84 (35.59) | 155 (41.01) | |
| CEA level (ng/mL) | |||
| ≤ 5 | 127 (53.81) | 203 (53.70) | 0.979 |
| > 5 | 109 (46.19) | 175 (46.30) | |
| Tumor location | |||
| Upper rectumc | 142 (60.17) | 234 (67.24) | 0.080 |
| Lower rectumc | 94 (39.83) | 144 (32.76) |
Notes: aLT- low-tie with ligation of inferior mesenteric artery (IMA) distal to the branching of the left colic artery (LCA) with en-bloc lymph node dissection around IMA and preservation of LCA, bHT- high-tie with ligation of IMA at its root proximal to the branching of LCA; cTumor in upper rectum – above the peritoneal reflection and lower rectum below the peritoneal reflection.
Abbreviations: ASA, American Society of Anesthesiologist; CEA, carcinoembryonic antigen.
Operative Findings of Rectal Cancer Patients with LT vs HT in Laparoscopic Anterior Resection of Rectal Cancer, N=614
| Clinicopathological Feature | LT 236 (38.44%) | HT 378 (61.56%) | p-value |
|---|---|---|---|
| Duration of surgery (min) | 146.0 ± 2.46 | 138.6 ± 2.01 | 0.021 |
| Time for IMA tie | 41.46 ± 0.66 | 32.69 ± 0.59 | 0.000 |
| Time for TME | 74.79 ± 2.13 | 73.46 ± 2.14 | 0.675 |
| Blood loss (mL) | 125.1 ± 5.74 | 113.6 ± 4.03 | 0.092 |
| Blood transfusion (n) | 9 (3.81) | 11 (2.91) | |
| Anastomosis from anal verge (cm) | 4.02 ± 0.15 | 3.93 ± 0.15 | 0.693 |
| No. of lymph nodes harvested | |||
| Total | 17.23 ± 0.30 | 17.51 ± 0.22 | 0.452 |
| Lymph nodes around IMA | 3.15± 0.06 | 3.23 ± 0.05 | 0.338 |
| Intermediate lymph nodes | 3.88 ± 0.09 | 3.72 ± 0.06 | 0.116 |
| Perirectal lymph nodes | 10.20 ± 0.30 | 10.56 ± 0.22 | 0.331 |
| Lymph node involvement | |||
| Lymph nodes around IMA | 13 (5.5) | 17 (4.49) | |
| Intermediate lymph nodes | 21 (8.89) | 37 (9.78) | |
| Perirectal lymph nodes | 87 (36.86) | 134 (35.45) | |
| Pathological proximal margin (cm) | 13.90 ± 0.09 | 14.04 ± 0.08 | 0.249 |
| Pathological distal margin (cm) | 2.87 ± 0.08 | 2.79 ± 0.06 | 0.444 |
Risk Factors for Anastomotic Leakage in Patients with LT vs HT in Laparoscopic Anterior Resection for Rectal Cancer, N=614
| Clinicopathological Feature | LT | HT | p value |
|---|---|---|---|
| Age ≥ 65 years | 105 | 194 | |
| AL | 13 (12.38) | 37 (19.02) | 0.148 |
| No-AL | 92 (87.62) | 157 (80.98) | |
| Male | 140 | 220 | |
| AL | 15 (10.71) | 21 (12.27) | 0.653 |
| No-AL | 125 (89.29) | 199 (87.73) | |
| Diabetes and/or hypertension | 45 | 48 | |
| AL | 5 (11.11) | 11 (22.91) | 0.132 |
| No-AL | 40 (88.89) | 37 (77.09) | |
| Neoadjuvant treatment | 34 | 43 | |
| AL | 5 (14.71) | 10 (23.26) | 0.347 |
| No-AL | 29 (85.29) | 33 (76.74) | |
| Tumor location in lower rectum | 94 | 144 | |
| AL | 10 (10.64) | 30 (20.83) | 0.040 |
| No-AL | 84 (89.36) | 114 (79.17) |
Hazard Ratio in for Anastomotic Leakage in Patients with LT vs HT in Laparoscopic Anterior Resection for Rectal Cancer, N=614
| Clinical Parameter | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p | HR | 95% CI | p | |
| IMA ligation (high-tie vs low-tie) | 1.62 | 1.56–1.65 | 0.047 | 1.71 | 0.99–2.94 | 0.051 |
| Age (≥65 vs <65 years) | 1.49 | 1.45–1.53 | 0.001 | 2.15 | 1.29–3.58 | 0.003 |
| Gender (male vs female) | 1.59 | 1.55–1.63 | 0.031 | 1.55 | 0.95–2.55 | 0.078 |
| Tumor Size (>5 cm vs ≤5 cm) | 1.30 | 1.27–1.34 | 0.421 | - | - | - |
| Diabetes and/or hypertension (Yes vs No) | 1.15 | 1.12–1.18 | 0.868 | - | - | - |
| Tumor location (low vs high) | 1.39 | 1.35–1.43 | 0.011 | 1.66 | 0.98–2.82 | 0.058 |
| Neoadjuvant treatment (Yes vs No) | 1.13 | 1.10–1.15 | 0.043 | 1.54 | 0.77–3.06 | 0.216 |
Abbreviations: HR, hazard ratio; CI, confidence interval; p, p value.
Long-Term Results of Overall Survival (OS) and Disease-Free Survival (DFS) in Patients with LT vs HT Anterior Resection of Rectal Cancer, N=614
| Long-Term Outcome | LT % | HT % | p-value |
|---|---|---|---|
| All patients (n=614) | 81.78 | 83.33 | 0.658 |
| With LN metastasis around IMA | 69.23 | 76.47 | 0.726 |
| Without LN metastasis around IMA | 84.30 | 86.15 | 0.543 |
| All patients (n=614) | 78.38 | 83.33 | 0.143 |
| With LN metastasis around IMA | 61.53 | 64.71 | 0.951 |
| Without LN metastasis around IMA | 79.37 | 84.21 | 0.148 |
| All patients (n=532) | 59.51 | 61.46 | 0.671 |
| With LN metastasis around IMA | 53.85 | 53.33 | 0.924 |
| Without LN metastasis around IMA | 59.90 | 61.86 | 0.667 |
| All patients (n=532) | 52.20 | 53.52 | 0.690 |
| With LN metastasis around IMA | 38.46 | 40.00 | 0.968 |
| Without LN metastasis around IMA | 53.13 | 54.17 | 0.723 |
Figure 3Long-term outcomes in the low-tie groups and high-tie groups. (A) 3-years OS with all patients, LN metastasis around IMA patients, and without LN metastasis around IMA patients; (B) 3-years DFS with all patients, LN metastasis around IMA patients, and without LN metastasis around IMA patients; (C) 5-years OS with all patients, LN metastasis around IMA patients, and without LN metastasis around IMA patients; (D) 5-years DFS with all patients, LN metastasis around IMA patients, and without LN metastasis around IMA patients.